JP2017522890A5 - - Google Patents

Info

Publication number

JP2017522890A5

JP2017522890A5 JP2017504814A JP2017504814A JP2017522890A5 JP 2017522890 A5 JP2017522890 A5 JP 2017522890A5 JP 2017504814 A JP2017504814 A JP 2017504814A JP 2017504814 A JP2017504814 A JP 2017504814A JP 2017522890 A5 JP2017522890 A5 JP 2017522890A5

Authority

JP

Japan

Prior art keywords

seq

amino acid

absence

acid sequence

subject

Prior art date

2014-12-30

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Granted

Links

• Espacenet
• Global Dossier
• Discuss

• 150000001413 amino acids Chemical class 0.000 claims description 17
• 230000035772 mutation Effects 0.000 claims description 10
• 229960005395 cetuximab Drugs 0.000 claims description 8
• 239000004475 Arginine Substances 0.000 claims description 7
• 235000001014 amino acid Nutrition 0.000 claims description 7
• ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 7
• 229960001972 panitumumab Drugs 0.000 claims description 6
• 125000000637 arginyl group Chemical group N[C@@H](CCCNC(N)=N)C(=O)* 0.000 claims description 5
• AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims description 4
• 239000004473 Threonine Substances 0.000 claims description 4
• 235000018417 cysteine Nutrition 0.000 claims description 4
• XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims description 4
• 101150039808 Egfr gene Proteins 0.000 claims description 3
• 108700021358 erbB-1 Genes Proteins 0.000 claims description 3
• 239000004472 Lysine Substances 0.000 claims description 2
• KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 2
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 15
• 238000000034 method Methods 0.000 claims 7
• 238000000338 in vitro Methods 0.000 claims 6
• 108090000765 processed proteins & peptides Proteins 0.000 claims 6
• 238000011269 treatment regimen Methods 0.000 claims 5
• 108091034117 Oligonucleotide Proteins 0.000 claims 4
• ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims 3
• 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 claims 3
• 125000001909 leucine group Chemical group [H]N(*)C(C(*)=O)C([H])([H])C(C([H])([H])[H])C([H])([H])[H] 0.000 claims 3
• 230000004043 responsiveness Effects 0.000 claims 3
• 125000000341 threoninyl group Chemical group [H]OC([H])(C([H])([H])[H])C([H])(N([H])[H])C(*)=O 0.000 claims 3
• DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims 2
• 239000012634 fragment Substances 0.000 claims 2
• 238000003205 genotyping method Methods 0.000 claims 2
• 238000000734 protein sequencing Methods 0.000 claims 2
• 239000004471 Glycine Substances 0.000 claims 1
• 101000851181 Homo sapiens Epidermal growth factor receptor Proteins 0.000 claims 1
• 102100038332 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Human genes 0.000 claims 1
• 101150063858 Pik3ca gene Proteins 0.000 claims 1
• MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims 1
• 101150048834 braF gene Proteins 0.000 claims 1
• 239000003153 chemical reaction reagent Substances 0.000 claims 1
• 102000045108 human EGFR Human genes 0.000 claims 1
• 238000011285 therapeutic regimen Methods 0.000 claims 1
• 108010004729 Phycoerythrin Proteins 0.000 description 9
• 102000052116 epidermal growth factor receptor activity proteins Human genes 0.000 description 7
• 108700015053 epidermal growth factor receptor activity proteins Proteins 0.000 description 7
• YOHYSYJDKVYCJI-UHFFFAOYSA-N n-[3-[[6-[3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]phenyl]cyclopropanecarboxamide Chemical compound FC(F)(F)C1=CC=CC(NC=2N=CN=C(NC=3C=C(NC(=O)C4CC4)C=CC=3)C=2)=C1 YOHYSYJDKVYCJI-UHFFFAOYSA-N 0.000 description 7
• 238000004458 analytical method Methods 0.000 description 3
• 238000001917 fluorescence detection Methods 0.000 description 3
• 239000013642 negative control Substances 0.000 description 3
• 238000006467 substitution reaction Methods 0.000 description 3
• 206010028980 Neoplasm Diseases 0.000 description 2
• 238000007481 next generation sequencing Methods 0.000 description 2
• 239000002773 nucleotide Substances 0.000 description 2
• 125000003729 nucleotide group Chemical group 0.000 description 2
• 238000001574 biopsy Methods 0.000 description 1
• 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
• 238000007480 sanger sequencing Methods 0.000 description 1